New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 12, 2014
05:47 EDTTRIVTriVascular initiated with an Outperform at Credit Suisse
Target $17.
News For TRIV From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 13, 2014
07:30 EDTTRIVCredit Suisse to hold a conference
Healthcare Conference is being held in Scottsdale, Arizona on November 10-13 with webcasted company presentations to begin on November 13 at 11 am; not all company presentations may be webcasted. Webcast Link
November 11, 2014
08:36 EDTTRIVTriVascular growth trajectory intact, says Canaccord
Canaccord would be buyers of TriVascular, citing its strong top-line growth and gross margin expansion that the firm feels is not reflected in the stock's current valuation. The firm also sees strong clinician interest in the company's OVATION system. Canaccord reiterates its Buy rating and $19 price target on TriVascular shares.
November 10, 2014
16:15 EDTTRIVTriVascular reports Q3 EPS (69c), consensus (63c)
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use